• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCR4 通过 YAP 信号通路介导基质硬度诱导的 UBTD1 下调促进肝癌进展。

CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.

机构信息

Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an 710061, China.

Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an 710061, China.

出版信息

Theranostics. 2020 Apr 27;10(13):5790-5801. doi: 10.7150/thno.44789. eCollection 2020.

DOI:10.7150/thno.44789
PMID:32483419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7255012/
Abstract

: Increasing evidence indicates that the physical environment is a critical mediator of tumor behavior. Hepatocellular carcinoma (HCC) develops in an altered biomechanical environment, and increased matrix stiffness is a strong predictor of HCC development. C-X-C chemokine receptor type 4 (CXCR4) is known to trigger HCC progression. However, CXCR4 as a mediator of mechanical cues in HCC is not well characterized. : qRT-PCR, Western blot and IHC were used to detect the CXCR4 expression in different matrix stiffness gels. MTT was used to measure the cell proliferation of HCC cells. Immunoblotting was used for detection of epithelial-to-mesenchymal transition (EMT) and stemness on the matrix stiffness. Immunofluorescence (IF) was used to detect the nuclear location in HCC cells. IP was used to show the interaction between YAP, UbcH5c and β-TrCP. : We identified CXCR4 as a critical intracellular signal transducer that relays matrix stiffness signals to control mechano-sensitive cellular activities through ubiquitin domain-containing protein 1 (UBTD1)-mediated YAP signaling pathway. We found that CXCR4 expression was remarkably up-regulated in HCC cells with increasing matrix stiffness and mediated proliferation, epithelial to mesenchymal transition, and stemness. Mechanistically, matrix stiffness acts through CXCR4 to decrease the levels of UBTD1, which is involved in the proteasome-dependent degradation of YAP, a major cell mechano-transducer. UBTD1 interacted with components of the YAP degradation complex and promoted the interaction between YAP and its E3 ubiquitin ligase β-TrCP. UBTD1 knockdown decreased YAP ubiquitylation and resulted in the activation of YAP-targeted genes and YAP downstream signaling. Downregulation of UBTD1 in HCC tissues correlated with malignant prognostic features and overall survival. Finally, luteolin, a natural product, suppressed matrix stiffness-induced biological effects and CXCR4-mediated YAP signaling pathway in HCC cells. : Our findings reveal CXCR4 as a molecular switch in mechano-transduction, thereby defining a mechano-signaling pathway from matrix stiffness to the nucleus.

摘要

越来越多的证据表明,物理环境是肿瘤行为的一个关键介质。肝细胞癌 (HCC) 发生在改变的生物力学环境中,基质硬度增加是 HCC 发展的一个强有力预测因子。已知 C-X-C 趋化因子受体 4 (CXCR4) 触发 HCC 进展。然而,CXCR4 作为 HCC 中机械线索的介质尚未得到很好的描述。 :qRT-PCR、Western blot 和 IHC 用于检测不同基质硬度凝胶中 CXCR4 的表达。MTT 用于测量 HCC 细胞的增殖。免疫印迹用于检测基质硬度上的上皮-间充质转化 (EMT) 和干性。免疫荧光 (IF) 用于检测 HCC 细胞的核定位。IP 用于显示 YAP、UbcH5c 和 β-TrCP 之间的相互作用。 :我们确定 CXCR4 是一种关键的细胞内信号转导蛋白,它通过泛素结构域蛋白 1 (UBTD1) 介导的 YAP 信号通路将基质硬度信号传递到控制机械敏感细胞活动。我们发现,随着基质硬度的增加,CXCR4 在 HCC 细胞中的表达显著上调,并介导增殖、上皮-间充质转化和干性。在机制上,基质硬度通过 CXCR4 作用降低 UBTD1 的水平,UBTD1 参与 YAP 的蛋白酶体依赖性降解,YAP 是主要的细胞机械转导物。UBTD1 与 YAP 降解复合物的成分相互作用,并促进 YAP 与其 E3 泛素连接酶 β-TrCP 的相互作用。UBTD1 敲低降低了 YAP 的泛素化,导致 YAP 靶向基因和 YAP 下游信号的激活。HCC 组织中 UBTD1 的下调与恶性预后特征和总生存期相关。最后,木犀草素,一种天然产物,抑制基质硬度诱导的生物效应和 HCC 细胞中的 CXCR4 介导的 YAP 信号通路。 :我们的研究结果揭示了 CXCR4 作为机械转导中的分子开关,从而定义了从基质硬度到细胞核的机械信号通路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/d29cf653770e/thnov10p5790g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/acc19c74b626/thnov10p5790g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/871cc1039553/thnov10p5790g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/a6d1dadec01e/thnov10p5790g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/f4dbba724441/thnov10p5790g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/95b979386e9c/thnov10p5790g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/e205fc109f15/thnov10p5790g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/8612a8e2cc33/thnov10p5790g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/d29cf653770e/thnov10p5790g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/acc19c74b626/thnov10p5790g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/871cc1039553/thnov10p5790g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/a6d1dadec01e/thnov10p5790g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/f4dbba724441/thnov10p5790g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/95b979386e9c/thnov10p5790g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/e205fc109f15/thnov10p5790g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/8612a8e2cc33/thnov10p5790g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704f/7255012/d29cf653770e/thnov10p5790g008.jpg

相似文献

1
CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.CXCR4 通过 YAP 信号通路介导基质硬度诱导的 UBTD1 下调促进肝癌进展。
Theranostics. 2020 Apr 27;10(13):5790-5801. doi: 10.7150/thno.44789. eCollection 2020.
2
UBTD1 is a mechano-regulator controlling cancer aggressiveness.UBTD1 是一种机械调节因子,控制着癌症的侵袭性。
EMBO Rep. 2019 Apr;20(4). doi: 10.15252/embr.201846570. Epub 2019 Feb 25.
3
Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.Fbxw7是一种独立的预后标志物,通过调节YAP丰度诱导肝癌细胞凋亡和生长停滞。
Mol Cancer. 2014 May 17;13:110. doi: 10.1186/1476-4598-13-110.
4
The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.缺氧条件下的间充质干细胞通过 YAP 介导的脂生成重编程促进肝癌进展。
J Exp Clin Cancer Res. 2019 May 29;38(1):228. doi: 10.1186/s13046-019-1219-7.
5
SEPT6 drives hepatocellular carcinoma cell proliferation, migration and invasion via the Hippo/YAP signaling pathway.SEPT6 通过 Hippo/YAP 信号通路驱动肝癌细胞增殖、迁移和侵袭。
Int J Oncol. 2021 Jun;58(6). doi: 10.3892/ijo.2021.5205. Epub 2021 Apr 13.
6
Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.卷曲蛋白 2 诱导的上皮间质转化与肝癌中的血管生成拟态、干性和 Hippo 信号通路相关。
Cancer Sci. 2019 Apr;110(4):1169-1182. doi: 10.1111/cas.13949. Epub 2019 Mar 6.
7
Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma.视网膜脱氢酶 5(RHD5)通过调节 Hippo/YAP 信号通路抑制肝癌转移。
Int J Med Sci. 2020 Jul 19;17(13):1897-1908. doi: 10.7150/ijms.46091. eCollection 2020.
8
MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.MEIS2C 和 MEIS2D 通过 Wnt/β-catenin 和 hippo/YAP 信号通路促进肝癌的肿瘤进展。
J Exp Clin Cancer Res. 2019 Oct 17;38(1):417. doi: 10.1186/s13046-019-1417-3.
9
Matrix stiffening facilitates stemness of liver cancer stem cells by YAP activation and BMF inhibition.基质僵硬通过 YAP 激活和 BMF 抑制促进肝癌干细胞的干性。
Biomater Adv. 2024 Oct;163:213936. doi: 10.1016/j.bioadv.2024.213936. Epub 2024 Jul 1.
10
Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.抑制 CXCR4 通过 Hippo-YAP 信号通路调节 NSCLC 的上皮间质转化。
Cell Biol Int. 2018 Sep;42(10):1386-1394. doi: 10.1002/cbin.11024. Epub 2018 Jul 17.

引用本文的文献

1
Substrate stiffness regulates triple-negative breast cancer signaling through CXCR4 receptor dynamics.底物硬度通过CXCR4受体动力学调节三阴性乳腺癌信号传导。
Sci Rep. 2025 Aug 13;15(1):29621. doi: 10.1038/s41598-025-14495-x.
2
Tumor extracellular matrix enhances invasive gene expression of breast cancer cells in 3D patient-derived scaffolds.肿瘤细胞外基质增强了三维患者来源支架中乳腺癌细胞的侵袭性基因表达。
Sci Rep. 2025 Jul 29;15(1):27642. doi: 10.1038/s41598-025-12196-z.
3
Identification of matrix stiffness-related molecular subtypes in HCC via integrating multi-omics analysis and machine learning algorithms.

本文引用的文献

1
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date.非侵入性纤维化测量在非酒精性脂肪性肝病/非酒精性脂肪性肝炎中的应用:迄今进展
Pharmaceut Med. 2019 Dec;33(6):451-463. doi: 10.1007/s40290-019-00305-z.
2
Mechanophysical Cues in Extracellular Matrix Regulation of Cell Behavior.细胞外基质调节细胞行为的力学线索。
Chembiochem. 2020 May 4;21(9):1254-1264. doi: 10.1002/cbic.201900686. Epub 2020 Mar 2.
3
Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1.
通过整合多组学分析和机器学习算法鉴定肝癌中与基质硬度相关的分子亚型。
J Transl Med. 2025 Jul 1;23(1):716. doi: 10.1186/s12967-025-06733-7.
4
Matrix stiffness-driven cancer progression and the targeted therapeutic strategy.基质硬度驱动的癌症进展及靶向治疗策略
Mechanobiol Med. 2023 Aug 3;1(2):100013. doi: 10.1016/j.mbm.2023.100013. eCollection 2023 Dec.
5
Exploring potential diagnostic markers and therapeutic targets for type 2 diabetes mellitus with major depressive disorder through bioinformatics and in vivo experiments.通过生物信息学和体内实验探索2型糖尿病合并重度抑郁症的潜在诊断标志物和治疗靶点。
Sci Rep. 2025 May 15;15(1):16834. doi: 10.1038/s41598-025-01175-z.
6
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis.子宫内膜癌中的细胞外基质硬度:通过ROCK1/YAP1轴驱动肿瘤进展并调节治疗敏感性
Cell Death Dis. 2025 May 14;16(1):380. doi: 10.1038/s41419-025-07697-8.
7
CDK4/6-mediated phosphorylation of DUB3 promotes YAP1 stability and hepatocellular carcinoma progression.CDK4/6介导的DUB3磷酸化促进YAP1稳定性及肝细胞癌进展。
Cell Death Discov. 2025 Apr 30;11(1):212. doi: 10.1038/s41420-025-02493-x.
8
Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer.细胞外基质硬度:肿瘤进展机制及癌症治疗潜力
Exp Hematol Oncol. 2025 Apr 10;14(1):54. doi: 10.1186/s40164-025-00647-2.
9
Unveiling the potential of biomechanics in pioneering innovative strategies for cancer therapy.揭示生物力学在开拓癌症治疗创新策略方面的潜力。
Theranostics. 2025 Feb 10;15(7):2903-2932. doi: 10.7150/thno.108605. eCollection 2025.
10
ITGB1/FERMT1 mechanoactivation enhances CD44 characteristic stemness in oral squamous cell carcinoma via ubiquitin-dependent CK1α degradation.整合素β1/踝蛋白1机械激活通过泛素依赖性细胞周期蛋白依赖性激酶1α降解增强口腔鳞状细胞癌中CD44的特征干性。
Oncogene. 2025 Jun;44(20):1530-1544. doi: 10.1038/s41388-025-03317-z. Epub 2025 Mar 5.
转移前生态位触发 SDF-1/CXCR4 轴,并通过下调 Prrx1 促进肝细胞循环肿瘤细胞在器官中的定植。
J Exp Clin Cancer Res. 2019 Nov 21;38(1):473. doi: 10.1186/s13046-019-1475-6.
4
Mechanotransduction in Liver Diseases.肝疾病中的力学转导
Semin Liver Dis. 2020 Feb;40(1):84-90. doi: 10.1055/s-0039-3399502. Epub 2019 Nov 4.
5
YAP/TAZ Related BioMechano Signal Transduction and Cancer Metastasis.YAP/TAZ相关的生物力学信号转导与癌症转移
Front Cell Dev Biol. 2019 Oct 4;7:199. doi: 10.3389/fcell.2019.00199. eCollection 2019.
6
TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression.TCF12 通过上调 CXCR4 表达促进肝细胞癌的发生和转移。
Theranostics. 2019 Aug 12;9(20):5810-5827. doi: 10.7150/thno.34973. eCollection 2019.
7
Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.长链非编码 RNA AGAP2-AS1 作为竞争性内源性 RNA,通过海绵吸附 miR-16-5p 而上调 ANXA11 的表达,促进肝癌的增殖和转移。
J Exp Clin Cancer Res. 2019 May 14;38(1):194. doi: 10.1186/s13046-019-1188-x.
8
CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy.CXCR4拮抗剂可减轻扩张型心肌病的心脏纤维化并改善心脏功能。
Front Pharmacol. 2019 Feb 19;10:117. doi: 10.3389/fphar.2019.00117. eCollection 2019.
9
UBTD1 is a mechano-regulator controlling cancer aggressiveness.UBTD1 是一种机械调节因子,控制着癌症的侵袭性。
EMBO Rep. 2019 Apr;20(4). doi: 10.15252/embr.201846570. Epub 2019 Feb 25.
10
The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.CXCL12(SDF-1)/CXCR4 趋化因子轴:致癌特性、分子靶向和用于癌症治疗的合成及天然产物 CXCR4 抑制剂。
Chin J Nat Med. 2018 Nov;16(11):801-810. doi: 10.1016/S1875-5364(18)30122-5.